Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunovant (IMVT) Prepaid Assets (2019 - 2026)

Immunovant filings provide 7 years of Prepaid Assets readings, the most recent being $46.8 million for Q4 2025.

  • Quarterly Prepaid Assets rose 31.26% to $46.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46.8 million through Dec 2025, up 31.26% year-over-year, with the annual reading at $51.7 million for FY2025, 107.63% up from the prior year.
  • Prepaid Assets hit $46.8 million in Q4 2025 for Immunovant, down from $49.7 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $51.7 million in Q1 2025 and bottomed at $4.8 million in Q3 2021.
  • Average Prepaid Assets over 5 years is $24.8 million, with a median of $20.5 million recorded in 2022.
  • The largest annual shift saw Prepaid Assets decreased 18.96% in 2022 before it surged 330.45% in 2023.
  • Immunovant's Prepaid Assets stood at $13.5 million in 2021, then soared by 56.64% to $21.1 million in 2022, then decreased by 10.9% to $18.8 million in 2023, then surged by 89.43% to $35.6 million in 2024, then surged by 31.26% to $46.8 million in 2025.
  • Per Business Quant, the three most recent readings for IMVT's Prepaid Assets are $46.8 million (Q4 2025), $49.7 million (Q3 2025), and $50.9 million (Q2 2025).